Header Logo

Connection

Lesley Scott to Leukemia, Myelogenous, Chronic, BCR-ABL Positive

This is a "connection" page, showing publications Lesley Scott has written about Leukemia, Myelogenous, Chronic, BCR-ABL Positive.
  1. High CIP2A levels correlate with an antiapoptotic phenotype that can be overcome by targeting BCL-XL in chronic myeloid leukemia. Leukemia. 2016 06; 30(6):1273-81.
    View in: PubMed
    Score: 0,131
  2. Second generation tyrosine kinase inhibitors prevent disease progression in high-risk (high CIP2A) chronic myeloid leukaemia patients. Leukemia. 2015 Jul; 29(7):1514-23.
    View in: PubMed
    Score: 0,123
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.